checkAd

     132  0 Kommentare Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting - Seite 2

    Investor Contact

    Lesen Sie auch

    Peter Vozzo
    Westwicke/ ICR
    Office: 443.213.0505
    Cell: 443.377.4767
    Peter.Vozzo@Westwicke.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting - Seite 2 DEVON, Pa., April 15, 2021 (GLOBE NEWSWIRE) - Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the …